Olema Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
OLMA
CUSIP
68062P106
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 68062P106 since 12/18/2024, largest first.

Filer % of Class Filed
FMR LLC 13G/A
13.8% 8/6/2026
Event 6/30/2026
Paradigm Biocapital Advisors LP 13G/A
10.0% 2/14/2025
Event 12/31/2024
Biotechnology Value Fund L P 13D/A
9.8% 10/16/2026
Event 10/14/2026
Bain Capital Life Sciences Opportunities IV, L.P. 13G/A 8.2% 5/15/2026
Event 3/31/2026
Janus Henderson Group Ltd. 13G/A 7.2% 11/16/2026
Event 9/30/2026
BlackRock, Inc. 13G/A 7.1% 7/29/2026
Event 6/30/2026
Invus Global Management, LLC 13G
5.1% 3/20/2026
Event 3/16/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Logos Global Management LP 13D/A
4.7% 5/13/2025
Event 3/18/2025
Point72 Asset Management, L.P. 13G/A
2.3% 5/15/2025
Event 3/31/2025
Deep Track Capital, LP 13G/A
0% 2/13/2026
Event 12/31/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 182 102 M $880M
2026 Q2 186 102 M $1.28B
2026 Q1 203 102 M $1.51B
2025 Q4 204 90.7 M $2.27B
2025 Q3 130 68.3 M $668M
2025 Q2 125 70.5 M $301M
2025 Q1 137 65.9 M $248M
2024 Q4 160 71.3 M $415M
2024 Q3 133 58.7 M $700M
2024 Q2 130 57.9 M $627M
2024 Q1 128 56.1 M $635M
2023 Q4 114 51.6 M $717M
2023 Q3 98 47.3 M $584M
2023 Q2 88 36.4 M $329M
2023 Q1 67 33.5 M $117M
2022 Q4 69 33.3 M $81.6M
2022 Q3 74 33.4 M $92.1M
2022 Q2 77 34.2 M $139M
2022 Q1 92 36.4 M $155M
2021 Q4 98 38.4 M $360M
2021 Q3 79 36.7 M $1.01B
2021 Q2 70 37.4 M $1.05B
2021 Q1 75 35.2 M $1.16B
2020 Q4 58 35.1 M $1.66B